It is common for a NE prostate cancer phenotype to not express AR and PSA and common for amplification of the genes aurora kinase A (AURKA) and N-myc (MYCN (51), both of which were overexpressed in ACRJ-PC28 at RNA-seq level and MYC was detected at the protein level. Here, AURKA is linked to prostate cancer.